10 Best Genomics Stocks To Buy Right Now
Genomics is the study of genes and how they function.
Posts Tagged ‘NASDAQ:BMRN’
Here’s Why BioMarin Aristotle Large Cap Growth Strategy Divested From Pharmaceutical (BMRN)
Aristotle Atlantic Partners, LLC, an investment advisor, released its “Large Cap Growth Strategy” third quarter 2024 investor letter.
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q3 2024 Earnings Call Transcript
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q3 2024 Earnings Call Transcript October 29, 2024BioMarin Pharmaceutical Inc. beats earnings expectations.
10 Best Falling Stocks To Buy According to Hedge Funds
Analysts at Goldman Sachs on October 21st released a note forecasting that the S&P 500 average annual return of 13% for the past 10 years might come down to just 3% for the next...
16 Best Mid Cap Growth Stocks To Buy Now
Recent discussions among financial strategists emphasize the current stock market dynamics, particularly regarding the upcoming US elections.
Top 10 Stock Picks of Elliott Management
It was arguably one of the best years for hedge funds, going by the $67 billion returned to shareholders in 2023 as the overall equity markets shrugged off high interest rates...
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q2 2024 Earnings Call Transcript
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q2 2024 Earnings Call Transcript August 5, 2024BioMarin Pharmaceutical Inc. misses on earnings expectations.
Here’s Why Parnassus Value Equity Fund Sold BioMarin Pharmaceutical (BMRN)
Parnassus Investments, an investment management company, released the “Parnassus Value Equity Fund” first quarter 2024 investor letter.
Should You Hold BioMarin Pharmaceutical (BMRN) Despite Setback?
Scout Investments, Inc, an affiliate of Carillon Tower Advisers, released the “Carillon Scout Mid Cap Fund” first quarter 2024 investor letter.
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q1 2024 Earnings Call Transcript
BioMarin Pharmaceutical Inc. beats earnings expectations. Reported EPS is $0.71, expectations were $0.6. BioMarin Pharmaceutical Inc.
30 Biggest Biotechnology Companies in the World
In this article, we will be taking a look at the 30 biggest biotechnology companies in the world.
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q4 2023 Earnings Call Transcript
BioMarin Pharmaceutical Inc. misses on earnings expectations. Reported EPS is $0.18 EPS, expectations were $0.44.
20 Fastest Growing Biotech Companies in the US
In this article, we will be taking a look at the 20 fastest growing biotech companies in the US.
Wall Street Analysts Just Trimmed Price Targets for These 5 Stocks
In this article, we discuss the 5 stocks receiving price-target cut from analysts.
Billionaire Louis Bacon’s 10 Stock Picks with Huge Upside Potential
In this article, we discuss billionaire Louis Bacon's 10 stock picks with huge upside potential. To skip the details about Mr.
Top 20 Drug Companies in the US by Revenue
In this article, we will be taking a look at the top 20 drug companies in the US by revenue.
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q3 2023 Earnings Call Transcript
Operator: Hello and welcome to the BioMarin Pharmaceutical Third Quarter 2023 Conference Call. All lines have been placed on meet to prevent any background noise.
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q2 2023 Earnings Call Transcript
Operator: Thank you for joining BioMarin Second Quarterly Results Conference Call. Hosting today's call from BioMarin is Traci McCarty, Head of Investor Relations at BioMarin.
Analysts Are Cutting Price Targets of These 5 Stocks
In this article, we discuss the 5 stocks receiving price-target cut from analysts.
10 Martin Shkreli Stock Picks and Their Performance
In this article, we will take a look at the 10 Martin Shkreli stock picks and their performance.
14 Best Biotech Stocks To Buy According To Hedge Funds
In this piece, we will take a look at 14 best biotechnology stocks to buy according to hedge funds.
Here’s Why You Should Invest in BioMarin Pharmaceutical (BMRN)
Aristotle Atlantic Partners, LLC, an investment advisor, released its “Large Cap Growth Strategy” first quarter 2023 investor letter.
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q1 2023 Earnings Call Transcript
Operator: Welcome to the BioMarin Pharmaceuticals First Quarter Investor Update Call.
Is BioMarin Pharmaceutical (BMRN) an Attractive Investment?
ClearBridge Investments, an investment management company, released its “ClearBridge Sustainability Leaders Strategy” fourth 2022 investor letter.
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q4 2022 Earnings Call Transcript
Operator: Welcome to the BioMarin Fourth Quarter Investor Update Call.
Top Investors’ Stock Portfolio: 5 Mid-Cap Stocks To Buy
In this article, we discuss 5 best mid-cap stocks to buy according to top investors.
5 Best Genomics Stocks To Buy Now
Agilent Technologies, Inc. (NYSE:A) provides application-focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.
5 Best Biotech Stocks To Buy According To Hedge Funds
In this article, we discuss 5 best biotech stocks to buy according to hedge funds.
Should You Invest in BioMarin Pharmaceutical (BMRN)?
Carillon Tower Advisers, an investment management company, released its “Carillon Scout Mid Cap Fund” second quarter 2022 investor letter.
Top 10 Stock Picks of Roberto Mignone’s Bridger Management
In this article, we discuss the top 10 stock picks of Roberto Mignone's Bridger Management.
5 Best Biotech Stocks To Buy Now
In this article, we discuss 5 Best Biotech Stocks To Buy Now.
5 Best Healthcare Stocks To Buy Now According To Motley Fool’s 1623 Capital
In this article, we talk about the 5 best healthcare stocks to buy now according to Motley Fool's 1623 Capital.
Did Hedge Funds Catch A Break With BioMarin Pharmaceutical Inc. (BMRN)?
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
10 Jim Cramer Stocks to Buy in Q1 2022
In this article, we discuss the 10 Jim Cramer stocks to buy in Q1 2022.
Is BioMarin Pharmaceutical Inc. (BMRN) A Good Stock To Buy?
We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on can be a profitable strategy...
10 Healthcare and Software Stocks to Buy According to Michel Massoud’s Melqart Asset Management
In this article, we take a look at the 10 healthcare and software stocks to buy according to Michel Massoud’s Melqart Asset Management.
5 Biotech and Pharmaceutical Stocks to Buy According to Palo Alto Investors
In this article, we will discuss 5 biotech and pharmaceutical stocks to buy according to Palo Alto Investors based on Q2 holdings of the fund.
5 Best Genomic Stocks to Buy Now
In this article, we will take a look at the 5 best genomic stocks to buy now.
Hedge Funds Are Nibbling On BioMarin Pharmaceutical Inc. (BMRN)
A whopping number of 13F filings filed with U.S.
10 Stocks Stanley Druckenmiller is Selling
In this article, we discuss the 10 stocks Stanley Druckenmiller is selling.
Is BioMarin Pharmaceutical Inc. (BMRN) A Good Stock To Buy?
Hedge funds and large money managers usually invest with a focus on the long-term horizon and, therefore, short-lived dips or bumps on the charts usually don't make them change...
Here’s Why ClearBridge Sold its BioMarin Pharmaceutical (BMRN) Position
ClearBridge Investments, an investment management firm, published its “SMID Cap Growth Strategy” first quarter 2021 investor letter – a copy of which can be downloaded here...
Is BioMarin (BMRN) Stock A Buy or Sell?
In this article we will take a look at whether hedge funds think BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is a good investment right now.
Is BioMarin Pharmaceutical (BMRN) Stock a Buy For 2021?
Carillon Eagle Mid Cap Growth Fund recently released its Q3 2020 Investor Letter, a copy of which you can download here.
Is BioMarin Pharmaceutical (BMRN) a Smart Long-term Buy?
Alger Spectra Fund recently released its Q3 2020 Investor Letter, a copy of which you can download here.
Is BMRN A Good Stock To Buy Now?
Many prominent investors, including Warren Buffett, David Tepper and Stan Druckenmiller, have been cautious regarding the current bull market and missed out as the stock market...
Were Hedge Funds Right About Souring On BioMarin Pharmaceutical Inc. (BMRN)?
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first.
Should I Avoid BioMarin Pharmaceutical Inc. (BMRN)?
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Hedge Fund and Insider Trading News: Steven A Cohen, Crispin Odey, Ray Dalio, Warren Buffett, Adrigo Hedge, iMedia Brands Inc (IMBI), Estee Lauder Companies Inc (EL), and More
The $400 billion corner of quant investing known as risk parity has a history of doubt and division, and Bridgewater Associates has started a new chapter.
Were Hedge Funds Right About Piling Into BioMarin Pharmaceutical Inc. (BMRN)?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
